Monoamine Oxidase Inhibitors
Taking
repaglinide with monoamine oxidase inhibitors can increase your risk of low blood sugar (hypoglycemia). You may need to be monitored more closely, and your healthcare provider may need to adjust your repaglinide dose, especially when starting or stopping an MAOI.
Montelukast
Combining repaglinide with
montelukast can increase the level of repaglinide in your blood, which may increase your risk of side effects (especially dangerously low blood sugar). You healthcare provider may need to decrease your dose of repaglinide if you are taking these two medications together.
Nefazodone
Taking repaglinide and
nefazodone together can increase the level of repaglinide in your blood, possibly increasing your risk of side effects. Your healthcare provider may need to decrease your dose of repaglinide if you are taking these medications together.
Nonsteroidal Anti-Inflammatory Drugs
If repaglinide is combined with
NSAIDs, this can increase your risk of low blood sugar (hypoglycemia). You may need to be monitored more closely, and your healthcare provider may need to adjust your repaglinide dose, especially when stopping or starting an NSAID, depending on your particular situation.
Probenecid
Taking repaglinide with probenecid can increase your risk of low blood sugar (hypoglycemia). You may need to be monitored more closely, and your healthcare provider may need to adjust your repaglinide dose, especially when starting or stopping probenecid.
Protease Inhibitors
If repaglinide is combined with protease inhibitors, this can increase the level of repaglinide in your blood, which may increase your risk of side effects. Your healthcare provider may need to decrease your dose of repaglinide if you are taking these medications together.
Previous
Add this article to your Favorites
Email this article
Print